£30k-a-year prostate cancer drug too expensive for NHS
Thousands of men with advanced prostate cancer will be denied life-extending wonder drug because NHS watchdog says £30,000-a-year cost per treatment is too high The drug abiraterone cuts the risk of men dying within three years by a third Calls for the drug to be routinely offered to men have been rejected by NICE The … Read more